BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) 

75 Sidney Street, 4th Floor

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-299-5000 Fax: 617-995-4995


SEARCH JOBS

View Clinical Trials from BioPharm Insight



 Key Statistics


Email: info@aveopharma.com
Ownership: Public

Web Site: AVEO Oncology
Employees:
Symbol: AVEO
 





Collaborations

Merck & Co., Inc.  Cancer





 Company News
AVEO Oncology (AVEO), Biodesix, Inc. Strike Ficlatuzumab-Companion Diagnostic Pact, Bioesix To Put Up An Initial $15 Million To Fund Study 4/10/2014 6:57:50 AM    More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Hands Back Cancer Drug Rights To Struggling AVEO Oncology (AVEO) 3/21/2014 7:08:06 AM    More...
AVEO Oncology (AVEO) Reports Full Year 2013 Financial Results And Outlines 2014 Strategic Plan 3/14/2014 6:50:13 AM    More...
AVEO Oncology (AVEO) Announces Timing For Conference Call To Discuss Year-End 2013 Financial Results And Provide Strategic Update For 2014 3/4/2014 7:55:15 AM    More...
Astellas Pharma Inc. (ALPMY) Ditches AVEO Oncology (AVEO) Pact As Cancer Drug, Tivozanib, Strikes Out Once Again 2/14/2014 7:18:49 AM    More...
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO), Astellas Pharma Inc. (ALPMY) Discontinue Phase 2 Trial Of Tivozanib In Breast Cancer 1/30/2014 7:14:31 AM    More...
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO): Lead Drug Tivozanib Unlikely To Succeed In Colon Cancer Study 12/13/2013 6:57:09 AM    More...
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) Reports Third Quarter 2013 Financial Results 11/7/2013 8:57:41 AM    More...
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) to Present at the Morgan Stanley (MST) Global Healthcare Conference 9/4/2013 7:02:26 AM    More...
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) to Present at the Canaccord Genuity 33rd Annual Growth Conference 8/9/2013 6:53:43 AM    More...
12345678910...